Navigation Links
WuXi PharmaTech Schedules Second-Quarter 2009 Earnings Release
Date:7/20/2009

SHANGHAI, July 20 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quarter of 2009 after the New York Stock Exchange closes on Tuesday, August 11, 2009 (which will be Wednesday morning, August 12, 2009 Shanghai time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The earnings release will be available on the investor relations section of its website at http://www.wuxiapptec.com .

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) on Wednesday, August 12, 2009, to discuss the second-quarter 2009 financial results and recent business activities. The conference call may be accessed by calling:

        United States: 1-866-519-4004
        China (Landline): 800-819-0121
        China (Mobile): 400-620-8038
        Hong Kong: 800-933-053
        United Kingdom: 0-808-234-6646
        International: +65-6735-7955
        Conference ID: 19244798
        Web PIN: 8656

    A telephone replay will be available two hours after the call's completion
at:

        United States: 1-866-214-5335
        China North: 10-800-714-0386
        China South: 10-800-140-0386
        Hong Kong: 800-901-596
        United Kingdom: 0-800-731-7846
        International: +61-2-8235-5000
        Conference ID # 19244798

A live webcast of the conference call and replay will be available
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. WuXi PharmaTech Receives Award from BASF
2. WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
3. WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
4. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
5. WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference
6. WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release
7. Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA
8. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results
9. The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
10. Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052
11. Quest PharmaTech Announces Results Showing its Photosensitizer, SL052, is an Effective Immuno-Stimulant when combined with Immunotherapy for the Removal of Solid Tumors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire-USNewswir...ntists, policy makers, and funders today convened ...tive funding strategies at the inaugural Partneri...ashington-based center of the Milken Institute, co...sector collaborations needed to turn a scientific ...
(Date:12/2/2009)..., , LIBREVILLE, Gabon, December 2 /PRN...in Africa: Everyone,s Problem and Heritage" ,...diversity, 2-3 June 2010 the,Gabonese Republic is ...(Gabon) on the issue of safeguarding biological re... by government and state leaders, ministers,scien...
(Date:12/2/2009)..., , SINGAPORE, Dec. 2 ...on its novel oral JAK2 inhibitor, SB1518, at The A...and Exposition in New Orleans. ,, Data will be ... dose-escalation trial of SB1518 detailing its saf...mic (PK/PD) profile in dose levels ranging from 10...
(Date:12/2/2009)..., , SHANGHAI, Dec. 2 /PRNewswire-Asi...es; markets are in turmoil and uncertainty is part...hat the pharma industry has been,relatively immune... take a,vacation. , During the midst of t...iant Johnson & Johnson inaugurated an R&D ...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
...rmaceuticals, Inc. (Nasdaq: TPPH ) announced toda...ovember 5, 2007 at 12:00 p.m. Eastern Time,(10:00 ...quarter 2007,financial results and provide a compa...regarding its second quarter financial results on ...rticipate in the conference call, please dial 800-...
...y of Pediatrics National Conference & ...AST NORRITON, Pa., Oct. 29 Tengion,Inc., a leader...ndings from,a preclinical study being presented to...tional Conference and Exhibition demonstrate the a...estore bladder function in a,well- established pre...
...unced today that it,has received the European CE M...p(TM) System for cervical cancer screening. The CE..., safety and environmental requirements,that ensur...therlands, the,registration will allow the system ...r countries around the world that recognize the CE...
Other Biology Technology:Tapestry to Host Conference Call on November 5th to Discuss Third Quarter 2007 Financial Results 2Preclinical Efficacy Data Demonstrate Ability of Tengion's Neo-Bladder Augment to Restore Bladder Function 2Preclinical Efficacy Data Demonstrate Ability of Tengion's Neo-Bladder Augment to Restore Bladder Function 3Diamics Receives European CE Mark Approval for Its Pap-Map(TM) System for Cervical Cancer Screening 2
(Date:12/2/2009)...N - A team comprised of undergraduate students fro...honors in a national poster contest hosted by the ...ng (ISPE). , The annual contest highlights the r...t month at the ISPE Annual Meeting in San Diego, C...f a Posterior Criciate Ligament Tensioning Device,...
(Date:12/2/2009)...w study on the smokeless tobacco product called mo...entists in Minnesota to urge the tobacco industry ...s content of carcinogens. Their study is published... in Toxicology . It reports that this category of ... of certain toxic and cancer-causing substances. C...
(Date:12/2/2009)...le-walled nanotubescylinders of carbon about a nan...ntial applications such as ultrastrong fibers, ele...orage components for fuel cells. Thanks to a new d...e of Standards and Technology (NIST) and five part...: detection and destruction of an aggressive form ...
Breaking Biology News(10 mins):Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2Reconstructive Plastic Surgery Patients Honored for Giving Back 59589 1Reconstructive Plastic Surgery Patients Honored for Giving Back 59589 2Reconstructive Plastic Surgery Patients Honored for Giving Back 59589 3Reconstructive Plastic Surgery Patients Honored for Giving Back 59589 4Video 3A Cities and States Around the U S Recognize October 13 as Metastatic Breast Cancer Awareness Day 59586 1Video 3A Cities and States Around the U S Recognize October 13 as Metastatic Breast Cancer Awareness Day 59586 2Video 3A Cities and States Around the U S Recognize October 13 as Metastatic Breast Cancer Awareness Day 59586 3Micro Waste Corporation Ordered to Pay Sanitecs Attorney Fees 59583 1Micro Waste Corporation Ordered to Pay Sanitecs Attorney Fees 59583 2
...n that seems to be pivotal in lifting depression h...funded by the National Institutes of Health,s Nati...eficient in this protein, called p11, display depr... amounts behave as if they have been treated with ... a Rockefeller University neuroscientist who recei...
...ledge that one disease may prevent the onset of an...cowpox vaccines can prevent smallpox dates back to...iatrics at the Mattel Children,s Hospital at UCLA,... ways that one disease prevents another. , His fi...lic influences should be considered when looking f...
...ts have discovered that a stem cell factor overexp...llowing brain injury promotes tumor survival by in... in the April issue of Cancer Cell, examines the i...sues and may have substantial significance for des...most lethal types of tumor, malignant gliomas. , ...
Other Biology News:Nobelist discovers antidepressant protein in mouse brain 2Nobelist discovers antidepressant protein in mouse brain 3UCLA paper examines how one disease may prevent another 2Growth factor-promoting angiogenesis expressed in tumor cells and normal neurons 2
...terone Receptor (PR) Competitor Assay Kits are ide...ceptor binding compounds using fluorescence polari...n of glutathione transferase to the ligand binding...)] and a proprietary, fluorescently tagged progest...
Organic Acid Analysis Standard, 6 vials from Bio-Rad
...anys Molecular Imaging Systems group announces the...Imaging Systems, featuring high resolution cooled ...ce, luminescence, radiographic and chromogenic ima...nd 10x optical zoom lens provides spatial resoluti...
...particle shape and size analyzer offering a wide d... simplicity in mind. It is comprised of a chemical...l bench. The system is completely computer control...r different applications such as dry or where smal...
Biology Products: